GTSE-1 inhibitors are chemical compounds designed to target and modulate the function of the GTSE-1 (G2 and S-phase expressed-1) protein, which plays a role in cell cycle regulation. GTSE-1 is predominantly expressed during the S and G2 phases of the cell cycle and is known to interact with tubulin, the building blocks of microtubules, thereby influencing microtubule dynamics. As such, these inhibitors generally aim to alter the stability and behavior of microtubules through their interaction with GTSE-1, potentially leading to effects on mitotic progression and the structural integrity of cells. By inhibiting GTSE-1, these compounds can impact cell cycle checkpoints and processes like apoptosis and genomic stability, making them of particular interest in studies of cellular proliferation and cell cycle control.
Structurally, GTSE-1 inhibitors often belong to diverse chemical classes but share certain features that enable them to bind selectively to the GTSE-1 protein. These inhibitors may exhibit a range of molecular backbones, from small heterocyclic compounds to larger complex molecules, and often include functional groups capable of specific interactions with GTSE-1 binding sites. The specificity and potency of GTSE-1 inhibitors can vary greatly depending on their structure-activity relationship (SAR), which dictates their binding affinity and efficacy. Researchers studying GTSE-1 inhibitors focus on understanding how these molecules interact with the protein's structure to elucidate their mechanisms of action at the molecular level. Such studies often involve analyzing the inhibitors' effects on microtubule polymerization, cell cycle arrest, and protein-protein interactions within the cellular environment, providing insight into the fundamental roles of GTSE-1 in cell biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can alter gene expression by affecting chromatin structure. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, potentially reversing epigenetic silencing of genes. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA and inhibits transcription, potentially reducing GTSE-1 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and disrupts RNA polymerase action, which could decrease GTSE-1 mRNA synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis in eukaryotic organisms which could indirectly affect GTSE-1 levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus inhibits mTOR, a kinase involved in cell cycle progression and could thus influence GTSE-1 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, which might lead to reduced transcription and lower GTSE-1 levels. | ||||||
PF 477736 | 952021-60-2 | sc-362781 sc-362781A | 5 mg 25 mg | $115.00 $431.00 | ||
Chk1 inhibitors like PF-477736 target checkpoint kinase 1, possibly affecting the expression of cell cycle-regulated genes. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is a CDK4/6 inhibitor and may affect the transcription of genes regulated during the G1-S transition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which could modify transcription factor activity and downregulate GTSE-1. | ||||||